Minnesota featured in national life sciences report

Minneapolis-St. Paul is one of the leading biomanufacturing and med-tech hubs featured in a new report released by the Hickey Institute, division of Hickey & Associates, a global consulting firm specializing in site selection and location strategy.

According to the report, “Minneapolis–St. Paul stands out as one of the most important and mature markets for the medical device sector…offer[ing] a highly specialized workforce, strong engineering talent from local universities, and a deeply integrated supply chain for precision manufacturing. In addition, Minnesota’s legacy of regulatory expertise and FDA engagement gives companies in the region a strategic edge when navigating product development and approval processes.”

Hickey’s 2025 Life Sciences & Medtech Site Selection Strategy Report provides a comprehensive guide for economic development organizations, public officials and industry allies who want to better align local strengths with life sciences priorities. Its findings can be a tool for communities to better understand the evolving requirements for how companies choose to locate new research, manufacturing and commercialization operations. The report offers actionable insights for developing competitive, future-ready life sciences ecosystems.